



Left ventricular remodeling in hearts with tricuspid atresia:
Morphologic observations and possible basis for
ventricular dysfunction after surgery
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Objectives: This study was undertaken to assess the pattern of left ventricular
hypertrophy, the myocardial capillary network, and the extracellular matrix in hearts
with tricuspid atresia.
Methods: We examined 32 hearts with tricuspid atresia and 27 normal hearts from
control subjects with similar age and sex distribution. Wall thickness, inlet length,
and outlet length were obtained from the left ventricle. Immunohistochemical
staining for von Willebrand factor was used to label myocardial capillaries. By
means of computer-assisted morphometry, the following data were obtained from
the inlet, apex, and outlet of the left ventricle: transverse myocyte diameter, myocyte
nuclear volume fraction, capillary volume fraction, interstitial fibrous volume frac-
tion, and endocardial thickness.
Results: The wall thickness in affected hearts was not different from that in control
hearts. The left ventricular outlet length was significantly greater in the malformed
hearts (P  .005). The myocyte diameter did not differ from that in control hearts.
The capillary volume fraction was decreased in the malformed hearts (P  .001).
The interstitial fibrous deposition was greater in the malformed hearts at all sites
analyzed (P  .001). Fibrosis was greater in the inlet and apex (P  .004) and also
in the subendocardial half of the ventricular wall than in the subepicardial half.
According to a logistic regression model, age was the only variable associated with
the probability of occurrence of fibrosis.
Conclusions: Our findings in hearts with tricuspid atresia possibly represent chron-
ically induced volume overload in the presence of ischemia, rather than a typical
model of volume overload. A decreased capillary volume fraction may indicate a
greater susceptibility to ischemia. Fibrous deposition probably occurs early in life.
The application of the Fontan principle has improved survival andfunctional capacity for patients with univentricular atrioventricularconnections. However, most centers have documented ongoing mor-bidity and mortality after surgery.1,2 Abnormal ventricular function,both systolic and diastolic, is clearly related to the late outcome.Myocardial hypertrophy is certainly recognized as a risk factor for
the Fontan procedure.3 The systemic ventricle is chronically volume overloaded and
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subjected to longstanding hypoxemia and variable degrees
of pressure overload, factors implicated in the myocardial
remodeling process. In addition, the myocardium may be
intrinsically abnormal, as has been suggested by Ho and
colleagues4 and, more recently, by Sanchez-Quintana and
coworkers.5 In addition to the pathologic remodeling, ex-
pansion of cardiac mass during postnatal physiologic
growth also takes place.
Few studies have addressed ventricular remodeling in
hearts with univentricular atrioventricular connections.4-6
The purpose of this study was to analyze several aspects of
the ventricular remodeling in hearts with tricuspid atresia,
including myocardial hypertrophy, extracellular matrix dep-
osition, and capillary network.
Methods
We studied 32 hearts with tricuspid atresia, obtained at autopsy
from the pathology laboratory collection of the Heart Institute,
University of Sa˜o Paulo Medical School. The control group com-
prised 27 structurally normal hearts from children aged 1 day to 6
years who had died of non–cardiovascular-related diseases. Age
and sex distributions were similar for the two groups (study group
age 9.6 13.9 months, median 2.5 months, 19 male and 13 female
infants; control group age 9.6 17.4 months, median 3 months, 15
male and 12 female infants). The specimens were inspected after
a sequential segmental analysis. The following measurements were
obtained from the left ventricle (LV): thickness of the free wall at
the inlet (the level of the superior edge of the papillary muscles)
and at the outlet (the same plane relative to the apex-base axis),
inlet and outlet lengths (an estimation of cavity size), arterial valve
diameters, and the major diameter of the ventricular septal defect
(VSD). The VSD was considered restrictive when its major diam-
eter was smaller than that of the arterial valve emerging from the
rudimentary right ventricle. Transmural blocks of tissue were
taken from the LV wall at the sites used for the measurements of
wall thickness in the inlet and outlet and also from the apex of the
LV. The tissue was processed routinely for histologic examination,
and 5-m sections were stained with hematoxylin and eosin and
Masson trichrome stain. Histologic sections and staining consid-
ered to be technically inadequate were excluded from the analysis.
Morphometric Analysis
MYOCYTE TRANSVERSE DIAMETER. The morphometric measure-
ments were carried out with an interactive computer-assisted im-
age analyzer (Leica Quantimet; Leica Cambridge Ltd, United
Kingdom).7 To avoid interobserver variation, a single investigator
operated the analyzer.
The myocyte transverse diameter was measured at the level of
the nucleus in the mesocardial layer of the ventricular wall, irre-
spective of the orientation of the section. Final magnification was
400.
In a pilot study, the evolution of the mean values and variance
was analyzed to determine the number of measurements required.
The mean values of myocyte diameter in 20, 40, 60, 80, 100, 120,
140, 180, and 200 observations were obtained. We opted to mea-
sure 60 myocytes per section.
CAPILLARY VOLUME FRACTION. Immunohistochemical staining
for von Willebrand factor was used to label myocardial capillary
endothelial cells. The stained inlet LV sections containing circum-
ferentially oriented capillaries were imaged at a final magnification
of 1000. For each section 30 random fields 11,456 m2 in area
were analyzed. With computer-assisted morphometry and an in-
terposed grid of 598 points, incident points on myocardial capil-
laries were counted. The proportion of the points lying over the
structure of interest over the number of points in the grid was used
as a measure of the volume fraction, or volume density, of myo-
cardium occupied by that structure.8
NUCLEAR VOLUME FRACTION. With the same system described
previously and an interposed grid of 598 points, incident points on
myocyte nuclei were counted in sections of the LV inlet stained
with hematoxylin and eosin. For each section 25 random fields
were analyzed at the mesocardial layer of the ventricular wall.
QUANTIFICATION OF FIBROUS TISSUE. Fibrous content in the in-
terstitial space was estimated by analyzing at least 10 microscopic
fields in the subendocardial and subepicardial halves of the ven-
tricular wall at a magnification of 400 (final resolution of 0.48
m/pixel). Star-shaped scars and concentric perivascular fibrous
tissue were excluded from the analysis. The interstitial fibrous
volume fraction (IFVF) was expressed as a percentage of the
myocardial area. Microscars were described qualitatively.
ENDOCARDIAL THICKNESS. Linear measurements of the endocar-
dial thickness were obtained in histologic sections stained with
hematoxylin-eosin from the inlet, apex, and outlet of the LV. A
mean value was obtained from 10 measurements at each site.
Statistical Analysis
Values are given as means, SDs, and medians. Unpaired Student t
tests or Mann-Whitney tests as appropriate were used to compare
values between control and study groups. Comparisons between
subendocardial and subepicardial regions were done with the Wil-
coxon test. The Friedman test was carried out for multiple com-
parisons, followed by the Tukey procedure as modified by Nem-
enyi. Correlation coefficients were obtained by the Spearman
method. Logistic regression was used to identify independent
predictors of the occurrence of fibrosis. Data were analyzed with
SigmaStat 2.0 software (SPSS Inc, Chicago, Ill).
Results
Heart Specimens
The atrial arrangement was usual in all specimens. The
ventriculoarterial connection was concordant in 20 hearts
and discordant in 10. One of the remaining specimens
showed a common arterial trunk emerging from the domi-
nant LV, and another showed a double outlet from the LV.
Twenty specimens showed signs of previous surgical inter-
vention. Of these, 9 had a modified Blalock-Taussig shunt;
5 of them showed pulmonary artery banding, 3 with aortic
coarctation repair. Of the remaining specimens, 5 had a
Fontan-Kreutzer procedure (1 preceded by a modified Bla-
lock-Taussig shunt and another by pulmonary artery band-
ing) and 1 had undergone a Damus-Kaye-Stansel procedure
associated with a bidirectional Glenn anastomosis. Death
had occurred between 1 day and 2 years after surgery
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(median 15 days); 14 of the patients had died within the first
postoperative month. Additional data are shown in Table 1.
LV Hypertrophy
The inlet and outlet wall thicknesses were not different from
those in control hearts (Table 2). The LV outlet length was
significantly greater in the malformed hearts (95% confi-
dence interval for difference of means 0.19-1.01; P  .005
by t test). On microscopy, the myocyte transverse diameter
did not differ from the controls in any of the sites analyzed
(95% confidence intervals for difference of means 2.1 to
1.18 for inlet,2.29 to 0.95 for apex, and1.37 to 1.53 for
outlet, respectively; Table 3). There was no difference when
comparing inlet, apex, and outlet of the LV (P  .38 by
Friedman test). In addition, the myocyte nuclear volume
fraction was significantly smaller in the malformed hearts
TABLE 2. Gross measurements from the inlet and outlet of
the LV, comparing hearts with tricuspid atresia and control
hearts
Tricuspid atresia Control








0.70 0.21 0.70 0.70 0.22 0.60 .94
Inlet length
(cm)
3.19 0.76 3.10 2.97 0.63 2.90 .24
Outlet length
(cm)
3.69 0.84 3.55 3.05 0.63 2.95 .005
TABLE 1. Characteristics of patients
Case Sex Age (mo)
Ventriculoarterial
connection Additional diagnosis Previous operation Interval*
1 M 0.1 Discordant Coarctation None —
2 M 0.2 Concordant TAPVC None —
3 M 0.2 Concordant Restrictive VSD, PS MBTS 5 d
4 F 0.3 Concordant Restrictive VSD MBTS 6 d
5 F 0.3 Discordant Restrictive VSD, coarctation None —
6 F 0.4 Concordant Restrictive VSD, TAPVC MBTS 1 d
7 F 0.5 Concordant Restrictive VSD, PS MBTS 2 d
8 M 0.6 Discordant Coarctation None —
9 M 0.7 Concordant Coarctation None —
10 M 0.9 Concordant Restrictive VSD, pulmonary
atresia
None —
11 F 1 Concordant Pulmonary atresia MBTS 9 d
12 M 1.2 Discordant Coarctation None —
13 F 2 Discordant Restrictive VSD, coarctation None —
14 F 2 Concordant PAB 19 d
15 M 2 Concordant Restrictive VSD None —
16 F 2.3 Single outlet Truncus arteriosus communis None —
17 M 2.7 Discordant PS MBTS 38 d
18 M 3 Discordant Coarctation PAB plus coarctation repair 16 d
19 F 4 Concordant None —
20 M 6 Concordant Restrictive VSD Fontan-Kreutzer 1 d
21 F 6 Concordant Restrictive VSD MBTS 15 d
22 F 7 Concordant None —
23 F 8 Double-outlet LV Restrictive VSD, coarctation PAB plus coarctation repair 24 d
24 M 8 Discordant Restrictive VSD, coarctation PAB plus coarctation repair 2 mo
25 F 9 Concordant PS MBTS 5 mo
26 M 24 Discordant Restrictive VSD Bidirectional Glenn anastomosis plus
Damus-Kaye-Stansel operation
plus mitral valve replacement
3 d
27 M 26 Concordant PS MBTS 2 y
28 M 32 Concordant Restrictive VSD Fontan-Kreutzer 16 d
29 M 34 Discordant PAB 2.3 y
30 M 36 Concordant Restrictive VSD, PS Fontan-Kreutzer 12 d
31 M 36 Concordant PAB, Fontan-Kreutzer 3 mo
32 M 50 Concordant Restrictive VSD MBTS, Fontan-Kreutzer 2 d
TAPVC, Total anomalous pulmonary venous connection; PS, pulmonary valve stenosis; MBTS, modified Blalock-Taussig shunt; PAB, pulmonary artery
banding.
*Interval from surgery to death.
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(median value 2.4% vs 4.4%, P  .001 by Mann-Whitney
test).
Capillary Volume Fraction
The myocardial capillary volume fraction was significantly
smaller in hearts with tricuspid atresia than in normal con-
trol hearts (median value 6.8% vs 8.1%, P  .01 by Mann-
Whitney test).
Interstitial Fibrosis
The IFVF was significantly greater in the malformed hearts
at all three sites examined (Table 3 and Figure 1, A). The
LV inlet and apex were more fibrotic than the outlet in the
malformed hearts but not in the control group (P  .004 by
Friedman test). In addition, the IFVF was greater in the
subendocardial halves of the ventricular wall in the inlet and
apex of hearts with tricuspid atresia but not the control
hearts (P  .002 and P  .01, respectively, by Wilcoxon
test Figure 2).
There was a weak but significant positive correlation
between IFVF and the age of the patients in the study group
(rs  0.50, P  .006) but not the control group (rs  .16, P
 . 45).
The multivariate logistic regression model suggested that
age was the only variable associated with an increased
probability of occurrence of fibrosis, defined as IFVF
greater than 3%. The other variables included in the model
(type of ventriculoarterial connection, the presence of a
restrictive VSD, presence of aortic coarctation or interrup-
tion, decreased pulmonary blood flow physiology, and pre-
vious surgery) were not independent predictors of occur-
rence of fibrosis in the multivariate model. In fact, children
older than 3 months had an 8.3 times greater probability of
occurrence of fibrosis than had a younger population (odds
ratio 95% confidence interval 1.47-47.22, sensitivity 71.4%,
specificity 76.9%; Figure 3).
Myocardial Microscars
Myocardial microscars (Figure 1, B) were present in 7
specimens from patients aged 27 days through 50 months
(median 4 months). Five were apical and 4 were restricted
to the subendocardial half of the ventricular wall.
Endocardial Thickness
LV endocardial thickness was greater at the inlet and apex
of the malformed hearts than in the control hearts (Table 3).
Type of Ventriculoarterial Connection
The age at death was similar between the two groups
(concordant 3 days to 34 months, median 3.0 months;
discordant 6 days to 50 months, median 2.3 months). There
was no difference when comparisons were made between
hearts with concordant and discordant ventriculoarterial
connections to address the following variables: inlet wall
thickness (P  .09 by t test), inlet length (P  .5 by t test),
transverse myocyte diameter (P  .24 by t test); IFVF (P 
.19 by Mann-Whitney test), and endocardial thickness (P 
.76 by t test).
Discussion
The LV of the heart with tricuspid atresia plays a crucial
role because it functions as the only pumping chamber. Few
studies have addressed the myocardial structure of mal-
formed hearts, particularly in univentricular atrioventricular
connections.
LV Hypertrophy
In our study the LVs of the malformed hearts were dilated,
without a relative increase in the wall thickness correspond-
ing to eccentric hypertrophy, as would be expected in situ-
ations where there is predominantly volume overload.
These findings are in accordance with those described by
others6 in hearts with pulmonary atresia with intact ventric-
TABLE 3. Myocyte diameter, interstitial fibrosis and endocardial thickness in the inlet, apex, and outlet of the LV in control
hearts and those with tricuspid atresia
Myocyte diameter (m) Fibrosis (IFVF %) Endocardial thickness (m)
Mean  SD Median Mean  SD Median Mean  SD Median
Inlet
Tricuspid atresia 9.6 2.4 9.6 (25) 3.8 2.8 3.1 (29)† 53.9 40.1 41.8 (29)*
Control 10.0 2.6 9.8 (15) 1.0 0.7 1.0 (23) 24.0 19.7 14.3 (18)
Apex
Tricuspid atresia 9.6 2.1 10.6 (15) 2.6 2.0 2.0 (25)† 20.8 14.7 15.1 (28)*
Control 9.0 2.1 8.7 (14) 0.5 0.5 0.4 (19) 10.7 3.7 9.9 (19)
Outlet
Tricuspid atresia 8.9 1.9 9.0 (14) 2.1 1.8 1.6 (22)† 34.1 29.0 23.9 (22)
Control 9.0 1.8 9.4 (14) 0.6 0.5 0.4 (18) 19.0 13.2 14.8 (16)
In parentheses are shown the numbers of cases analyzed in each comparison (tricuspid atresia versus control).
*P  .01 versus control.
†P  .001 versus control.
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ular septum, suggesting that the ratio of LV mass to end-
diastolic volume may be inadequate in univentricular hearts.
We did not find specimens in our material with excessive
wall thickness, as demonstrated in an autopsy series of
patients who died after the Fontan procedure9 and also in a
clinical setting.10 This diversity in results is likely to be
related to the young age of death of the patients included in
our study, most younger than 1 year, and the relative paucity
of cases with discordant ventriculoarterial connection in
association with a restrictive VSD and subaortic stenosis, in
which setting conspicuous ventricular hypertrophy is more
frequent.
During the adaptive phase of elevated diastolic wall
stress in volume overloads, the ratio of wall thickness to
chamber radius remains constant as a result of proportional
growth in the transverse and longitudinal dimensions of the
myocyte. After the progression toward decompensation,
there is a disproportionate lengthening of the myocytes and
a dilated, thin-walled ventricular chamber.11 In this study
the myocyte transverse diameter in the affected hearts did
not differ from that in the control hearts. Although the
longitudinal dimension could not be obtained, it is likely
that these patients were in the maladaptive phase of eccen-
tric hypertrophy before death.
Experimental data have indicated that the myocyte nu-
clear volume increases with cellular hypertrophy.12 In ad-
dition, previous studies have demonstrated that human myo-
cytes are prevalently mononucleated.13 The myocyte
nuclear volume fraction could therefore be viewed as an
index of hypertrophy and of cell number in a given area of
the histologic section. The decreased nuclear volume frac-
tion found in hearts with tricuspid atresia relative to normal
control hearts is in agreement with a predominantly longi-
tudinal growth of the myocytes (eccentric hypertrophy).
However, we could not establish a parallel to the hypertro-
Figure 1. Photomicrographs of LV myocardium from child with
tricuspid atresia (original magnification 20, Masson trichrome
stain). A, Diffuse interstitial fibrosis stained in blue. B, Star-
shaped scar stained in blue.
Figure 2. Box and whisker plots comparing IFVF in subendocar-
dial and subepicardial halves of LV wall of hearts with tricuspid
atresia in three sites analyzed. Boxes represent median, upper,
and lower quartiles. P values are .002, .01, and .09, respectively,
for comparisons in inlet, apex, and outlet of LV.
Figure 3. Estimated probability of occurrence of fibrosis in rela-
tion to age of patients.
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phic process, either because one does not exist or because of
the relatively small number of cases analyzed.
Coronary Capillaries
The myocardial capillary network expands proportionally
during physiologic growth14 but may be inadequate under
conditions of hemodynamic overload, increasing the poten-
tial for ischemic damage in cardiac hypertrophy. Evidence
from animal and human studies indicates that capillary
growth in pressure overload hypertrophy does not fully
compensate for the increase in ventricular mass,15 although
limited capillary growth may occur in young patients16 and
during adaptation to a prolonged pressure overload.17 In
contrast, several experimental studies in volume overload
models suggest that the adaptation of the myocardial cap-
illary network is proportional to the degree of hypertro-
phy.18 Experimental data on the myocardial capillary supply
adaptation in response to hypoxia are controversial.15 Yet
hypoxia is considered to be an effective stimulus for growth
of endothelial cells.15 The finding of a decreased capillary
volume fraction in our cases might indicate a greater vul-
nerability of these hearts to ischemia.
Extracellular Matrix
Hearts with tricuspid atresia showed a higher proportion of
fibrous tissue than normal since the first weeks of life,
showing a positive correlation with increasing age. The
multivariate logistic regression model indicated that infants
older than 3 months had an 8.3 times greater probability of
occurrence of fibrosis than had younger infants, supporting
the view that the myocardium may be inherently abnor-
mal.4,5
It has been well documented that pressure overload car-
diac hypertrophy is accompanied by an increased accumu-
lation of collagen in the myocardium.19,20 Fibrosis of the
heart accompanies chronic elevations in circulating effector
hormones of the renin-angiotensin-aldosterone system,
when heart failure or unilateral renal artery stenosis impairs
renal perfusion.20 In contrast, most of the published exper-
imental data have indicated that interstitial collagen accu-
mulation does not change in response to induced volume
overload.21,22
Much attention is currently focused on the role of apo-
ptosis in the pathogenesis of cardiac disease. Apoptosis has
been implicated in a wide range of models, such as ischemia
and myocardial infarction, pressure overload hypertrophy,
cardiac rejection, and dilated cardiomyopathy.23 It may be a
contributing phenomenon in the pathologic remodeling in
hearts with tricuspid atresia.
The morphometric method permitted the discrimination
of the fibrous deposition across the ventricular wall. Hoyt
and colleagues7 compared the quantification of collagen in
histologic sections stained with Masson trichrome, per-
formed with a computer-assisted method similar to ours,
with those obtained from a hydroxyproline assay. The per-
centage of collagen from analysis of histologic sections
strongly correlated with the hydroxyproline level, with ex-
cellent intraobserver and interobserver concordance. Re-
sults were unaffected by variations in histochemical stain-
ing.
Our study showed a greater deposition of fibrous tissue
in the subendocardial half of the LV wall, following the
pattern found in concentric hypertrophy,24 dilated cardio-
myopathy,25 and ventricular remodeling after myocardial
infarction.26 This finding is not in agreement with observa-
tions by Ho and colleagues4 in hearts with tricuspid atresia.
Experimental studies of physiologic growth have demon-
strated a relatively lower capillary luminal volume in the
subendocardial layer, indicating a greater vulnerability of
this region to ischemic injury.27 In addition, the myocardial
tissue pressure and oxygen demands are greater in the
subendocardial portion of the wall. Thus the disturbance of
oxygen supply and demand may result in chronic tissue
injury and subendocardial fibrosis.
This analysis demonstrated regional variations in the
fibrous deposition, with the LV inlet and apex being more
fibrotic than the outlet in malformed hearts. This finding
could explain, at least in part, regional ventricular wall
motion abnormalities found in patients with univentricular
hearts before and after stages of Fontan reconstruction.28,29
The comparison according to the type of ventriculoarte-
rial connections did not show any significant difference in
the content of fibrous tissue. This finding is in conformity
with data published by Ho and colleagues,4 possibly reflect-
ing the dominant role of the LV.
The functional consequences of collagen remodeling
have been extensively demonstrated.30 It seems clear that
both systolic and diastolic properties may be affected. Clin-
ical trials with pharmacologic interventions directed toward
collagen remodeling in such malformed hearts should be
addressed in future studies.
Conclusion
On the whole, our findings in hearts with tricuspid atresia
are more likely to represent a chronically induced volume
overload in the presence of ischemia than to represent a
typical model of volume overload. Moreover, the pathologic
insult occurs in parallel with the expansion of cardiac mass
in a growing child. What remains to be clarified is why the
capillary network seems not to develop properly in the
presence of a strong potential stimulus for angiogenesis
(hypoxia).
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